MidSouth Bancorp, Inc. (MSL) shareholder Clayton Hilliard, Unloaded $128,700 in Stock; Medicines Co (MDCO) Has 0.78 Sentiment

February 28, 2018 - By Jerrie Dane

Not a long ago, the shareholder of Midsouth Bancorp Inc, Mr. Clayton Hilliard, sold number of company shares – 10,000, amounting to $128,700 US Dollars, based on an average weighted cost of $12.9 per each share. In the last month, he also unloaded 31,300 shares with a market value $416,540 USD. Clayton Hilliard currently possess 72,485 shares which make up exactly 0.44% of the Louisiana-based company’s market capitalization (total value of the shares outstanding). The transaction was made on February 28, 2018 and this act was unveiled in a report which was filed with the Security and Exchange Commission. This report is ready for use online here.

The Medicines Company, a biopharmaceutical company, provides medicines for patients in acute and intensive care hospitals worldwide. The company has market cap of $2.22 billion. The firm markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for patients undergoing percutaneous coronary intervention; Ionsys, a fentanyl iontophoretic transdermal system for the short term management of acute postoperative pain for adults requiring opioid analgesia in the hospital. It currently has negative earnings. It also markets Minocin IV, an intravenous formulation of a tetracycline-class antibiotic used for the treatment of infections due to susceptible strains of designated gram-negative bacteria; and Orbactiv, an intravenous antibiotic used for the treatment of adult patients with acute bacterial skin and skin structure infections, or caused or suspected to be caused by susceptible isolates of designated gram-positive microorganisms.

Since January 1, 0001, it had 1 insider buy, and 1 sale for $1.60 million activity.

The stock decreased 1.79% or $0.56 during the last trading session, reaching $30.72. About 525,438 shares traded. The Medicines Company (MDCO) has risen 16.70% since February 28, 2017 and is uptrending. It has by 0.00% the S&P500.

Sarissa Capital Management Lp holds 20.03% of its portfolio in The Medicines Company for 1.75 million shares. Bridger Management Llc owns 2.81 million shares or 6.23% of their US portfolio. Moreover, Antipodean Advisors Llc has 5.5% invested in the company for 176,000 shares. The California-based Venbio Select Advisor Llc has invested 4.94% in the stock. Three Bays Capital Lp, a Massachusetts-based fund reported 1.58 million shares.

Ratings analysis reveals 100% of The Medicines Co’s analysts are positive. Out of 2 Wall Street analysts rating The Medicines Co, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $45.0 while the high is $57.0. The stock’s average target of $51 is 66.02% above today’s ($30.72) share price. MDCO was included in 2 notes of analysts from November 8, 2016. RBC Capital Markets maintained The Medicines Company (NASDAQ:MDCO) on Tuesday, November 8 with “Outperform” rating. On Monday, December 5 the stock rating was initiated by H.C. Wainwright with “Buy”.

Analysts await MidSouth Bancorp, Inc. (NYSE:MSL) to report earnings on April, 26. They expect $0.12 earnings per share, down 20.00% or $0.03 from last year’s $0.15 per share. MSL’s profit will be $1.99M for 26.46 P/E if the $0.12 EPS becomes a reality. After $-0.15 actual earnings per share reported by MidSouth Bancorp, Inc. for the previous quarter, Wall Street now forecasts -180.00% EPS growth.

Since October 27, 2017, it had 1 insider buy, and 10 selling transactions for $788,197 activity. HILLIARD CLAYTON PAUL also sold $63,800 worth of MidSouth Bancorp, Inc. (NYSE:MSL) on Thursday, February 22. CLOUTIER C R had sold 17,000 shares worth $236,640 on Monday, February 5. Hargroder Andrew G had sold 3,000 shares worth $42,000. MCLEMORE JAMES R JR also bought $13,150 worth of MidSouth Bancorp, Inc. (NYSE:MSL) on Tuesday, February 6.

The stock decreased 1.55% or $0.2 during the last trading session, reaching $12.7. About 25,037 shares traded. MidSouth Bancorp, Inc. (NYSE:MSL) has risen 37.43% since February 28, 2017 and is uptrending. It has outperformed by 20.73% the S&P500.

Among 6 analysts covering MidSouth Bancorp (NYSE:MSL), 2 have Buy rating, 1 Sell and 3 Hold. Therefore 33% are positive. MidSouth Bancorp has $17 highest and $9.75 lowest target. $14.75’s average target is 16.14% above currents $12.7 stock price. MidSouth Bancorp had 18 analyst reports since September 22, 2015 according to SRatingsIntel. The rating was maintained by Keefe Bruyette & Woods with “Hold” on Tuesday, October 3. Sandler O’Neill maintained MidSouth Bancorp, Inc. (NYSE:MSL) on Thursday, February 1 with “Buy” rating. Raymond James downgraded the shares of MSL in report on Friday, December 16 to “Outperform” rating. Keefe Bruyette & Woods maintained the stock with “Hold” rating in Wednesday, June 7 report. The firm has “Outperform” rating by Hovde Group given on Monday, February 6. The stock of MidSouth Bancorp, Inc. (NYSE:MSL) earned “Hold” rating by Keefe Bruyette & Woods on Thursday, December 21. The rating was maintained by Stephens on Tuesday, August 1 with “Buy”. The company was upgraded on Monday, May 9 by Raymond James. Stephens maintained the shares of MSL in report on Monday, June 12 with “Buy” rating. On Friday, June 9 the stock rating was downgraded by Raymond James to “Underperform”.

Investors sentiment decreased to 2.18 in 2017 Q3. Its down 0.14, from 2.32 in 2017Q2. It worsened, as 6 investors sold MidSouth Bancorp, Inc. shares while 11 reduced holdings. 6 funds opened positions while 31 raised stakes. 9.28 million shares or 10.37% more from 8.40 million shares in 2017Q2 were reported. Northern Tru Corp stated it has 0% of its portfolio in MidSouth Bancorp, Inc. (NYSE:MSL). Basswood Capital Mngmt Ltd Liability holds 0.43% or 779,980 shares. Schwab Charles Investment Mngmt Inc holds 77,465 shares or 0% of its portfolio. Tiaa Cref Invest Management Limited Liability Co holds 24,606 shares or 0% of its portfolio. Panagora Asset Mgmt reported 349 shares. Morgan Stanley stated it has 0% of its portfolio in MidSouth Bancorp, Inc. (NYSE:MSL). Hotchkis Wiley Capital Llc holds 11,322 shares. Schneider Cap Mgmt holds 0.19% in MidSouth Bancorp, Inc. (NYSE:MSL) or 85,921 shares. The United Kingdom-based Legal General Public Ltd has invested 0% in MidSouth Bancorp, Inc. (NYSE:MSL). Manufacturers Life Insur The owns 14,003 shares. Deutsche State Bank Ag, a Germany-based fund reported 50,235 shares. Jpmorgan Chase reported 0% of its portfolio in MidSouth Bancorp, Inc. (NYSE:MSL). Ny State Common Retirement Fund holds 9,500 shares or 0% of its portfolio. Moreover, Naples Global Advsr Llc has 0.1% invested in MidSouth Bancorp, Inc. (NYSE:MSL). California State Teachers Retirement Sys accumulated 23,600 shares.